Morgan Stanley downgraded Keurig Dr Pepper to Equal Weight from Overweight with an unchanged price target of $37. The company’s earnings visibility is now priced into the shares, the analyst tells investors in a research note. The firm says part one of its early-July upgrade has played out with the market now viewing the company’s earnings visibility as solid. Meanwhile, the second part of the call has not fully played out, with an expected sales rebound in coffee not playing out as much as expected, with discounting from pod competitors limiting Keurig share and driving lower company owned-pod pricing, adds Morgan Stanley.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on KDP:
- HSBC neutral on Keurig Dr Pepper ahead of new CEO’s plan
- Keurig Dr Pepper initiated with a Hold at HSBC
- Chobani acquires La Colombe for $900M
- Keurig Dr Pepper Declares Quarterly Dividend
- KO, KDP, CELH See a Jump in Soda Sales
Questions or Comments about the article? Write to editor@tipranks.com